Loading
Hisamitsu Pharmaceutical Co.,Inc. is a listed company. Its insiders report their share dealings to EDINET (Japan FSA). In the past year (18 October 2025 to 18 October 2026), 7 filings came from 3 insiders.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Insider buying of Hisamitsu Pharmaceutical Co.,Inc. has been absent for the past year. The median gap between a trade and its publication by EDINET (Japan FSA) is 7 days. That lag is the time during which only the insider knows about the trade.
Across the 3,423 companies tracked on its exchange, the median is 3 filings; at 7 filings, this issuer sits above that mark.
Source: insider filings from EDINET (Japan FSA). Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
12 of 12 declarations
Kuwakou Pharmaceutical Co., Ltd. is a Japanese company specializing in the manufacture of pharmaceutical products, including medicines and medical devices. It is listed on the Tokyo Stock Exchange.